{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T05:57:33Z","timestamp":1648792653787},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T00:00:00Z","timestamp":1393545600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Innovative Medicine Initiative Joint Undertaking","award":["115008"],"award-info":[{"award-number":["115008"]}]},{"name":"European Union's Seventh Framework Programme","award":["FP7\/2007-2013"],"award-info":[{"award-number":["FP7\/2007-2013"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","europeanneuropsychopharmacology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.euroneuro.2013.11.010","type":"journal-article","created":{"date-parts":[[2013,11,28]],"date-time":"2013-11-28T04:16:15Z","timestamp":1385612175000},"page":"357-368","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Combining efficacy and completion rates with no data imputation: A composite approach with greater sensitivity for the statistical evaluation of active comparisons in antipsychotic trials"],"prefix":"10.1016","volume":"24","author":[{"given":"Jonathan","family":"Rabinowitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nomi","family":"Werbeloff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivo","family":"Caers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francine S.","family":"Mandel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Jaeger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Stauffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Menard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce J.","family":"Kinon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shitij","family":"Kapur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2013.11.010_bib2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1056\/NEJMc052822","article-title":"Antipsychotic drugs and schizophrenia","volume":"354","author":"Duan","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2013.11.010_bib1","unstructured":"Guideline on Missing Data in Confirmatory Clinical Trials, 2010. In: Committee for Medicinal Products for Human Use (CHMP) (Ed.). European Medicines Agency, London, UK"},{"key":"10.1016\/j.euroneuro.2013.11.010_bib3","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1176\/appi.ajp.2009.09040458","article-title":"Last observation carried forward versus mixed models in the analysis of psychiatric clinical trials","volume":"166","author":"Hamer","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.11.010_bib4","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2013.11.010_bib5","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1176\/appi.ajp.160.8.1396","article-title":"Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol","volume":"160","author":"Lieberman","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.11.010_bib6","series-title":"Statistical Analysis with Missing Data","author":"Little","year":"1987"},{"key":"10.1016\/j.euroneuro.2013.11.010_bib7","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0006-3223(02)01867-X","article-title":"Assessing and interpreting treatment effects in longitudinal clinical trials with missing data","volume":"53","author":"Mallinckrodt","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.11.010_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.eurpsy.2005.09.009","article-title":"Meta-analysis of drop-out rates in randomised clinical trials, comparing typical and atypical antipsychotics in the treatment of schizophrenia","volume":"21","author":"Martin","year":"2006","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.euroneuro.2013.11.010_bib9","series-title":"Handbook of Social Psychology","first-page":"289","article-title":"Selected quantitative techniques","author":"Mosteller","year":"1954"},{"key":"10.1016\/j.euroneuro.2013.11.010_bib10","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/clpt.2011.340","article-title":"The prevention and treatment of missing data in clinical trials: an FDA perspective on the importance of dealing with it","volume":"91","author":"O'Neill","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.euroneuro.2013.11.010_bib11","series-title":"The Prevention and Treatment of Missing Data in: Committee on National Statistics Division of Behavioral and Social Sciences and Education (Ed.)","author":"Panel on Handling Missing Data in Clinical Trials","year":"2010"},{"key":"10.1016\/j.euroneuro.2013.11.010_bib12","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/schbul\/sbm107","article-title":"A composite approach that includes dropout rates when analyzing efficacy data in clinical trials of antipsychotic medications","volume":"34","author":"Rabinowitz","year":"2008","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.euroneuro.2013.11.010_bib13","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/schbul\/sbn005","article-title":"Dropout rates in randomized clinical trials of antipsychotics: a meta-analysis comparing first- and second-generation drugs and an examination of the role of trial design features","volume":"35","author":"Rabinowitz","year":"2009","journal-title":"Schizophr. Bulletin"},{"key":"10.1016\/j.euroneuro.2013.11.010_bib14","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/(SICI)1097-0258(19970615)16:11<1225::AID-SIM548>3.0.CO;2-Y","article-title":"Testing for treatment differences with dropouts present in clinical trials--a composite approach","volume":"16","author":"Shih","year":"1997","journal-title":"Stat. Med."},{"key":"10.1016\/j.euroneuro.2013.11.010_bib15","first-page":"53","article-title":"On the composite approach to dropouts in clinical trials","volume":"11","author":"Shih","year":"2001","journal-title":"Stat. Sin."},{"key":"10.1016\/j.euroneuro.2013.11.010_bib16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/10543400802609797","article-title":"MMRM vs. LOCF: a comprehensive comparison based on simulation study and 25 NDA datasets","volume":"19","author":"Siddiqui","year":"2009","journal-title":"J. Biopharm. Stat."},{"key":"10.1016\/j.euroneuro.2013.11.010_bib17","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1037\/0033-2909.97.2.334","article-title":"Combining and comparing significance levels from nonindependent hypothesis tests","volume":"97","author":"Strube","year":"1985","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.euroneuro.2013.11.010_bib18","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s002130100711","article-title":"Dropout rates in randomised antipsychotic drug trials","volume":"155","author":"Wahlbeck","year":"2001","journal-title":"Psychopharmacology (Berl)"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X13003416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X13003416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T12:57:01Z","timestamp":1539003421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X13003416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0924977X13003416"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2013.11.010","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combining efficacy and completion rates with no data imputation: A composite approach with greater sensitivity for the statistical evaluation of active comparisons in antipsychotic trials","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2013.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. and ECNP.","name":"copyright","label":"Copyright"}]}}